AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • November 3rd, 2017 • Cempra, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 2017 by and among, Melinta Therapeutics, Inc., f/k/a Cempra, Inc., a Delaware corporation, Cempra Pharmaceuticals, Inc., a Delaware corporation, CEM-102 Pharmaceuticals, Inc., a Delaware corporation, and Melinta Subsidiary Corp., f/k/a Melinta Therapeutics, Inc., a Delaware corporation (each an “Indemnitor” and collectively, the “Indemnitors”), and (“Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 3rd, 2017 • Cempra, Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into this this 30th day of October 2017, by and between Melinta Therapeutics, Inc., a Delaware corporation (the “Company”), and Daniel Mark Wechsler (“Executive”). Upon the closing of the transactions contemplated by that certain Agreement and Plan of Merger and Reorganization (the “Acquisition Agreement”), dated August 8, 2017, by and among Cempra, Inc. (“Cempra”), a Delaware corporation, Castle Acquisition Corp., a Delaware corporation and the Company, this Agreement shall be assumed by Cempra and all references herein to the Company shall refer to Cempra, which shall be renamed “Melinta Therapeutics, Inc.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 3rd, 2017 • Cempra, Inc. • Pharmaceutical preparations • Delaware
This REGISTRATION RIGHTS AGREEMENT, dated as of November 3, 2017 (this “Agreement”), is made among Cempra, Inc., a Delaware corporation (the “Company”), Vatera Healthcare Partners LLC, a Delaware limited liability company (the “Vatera Shareholder”), and the other shareholders of the Company set forth on the signature pages hereto (the “Other Shareholders” and, together with the Vatera Shareholder, the “Shareholders” or individually a “Shareholder”).
